arBtrage CAPITALIZING MARKETS — checking… Sign in Sign up
Calendar /

Qiagen N.V.

QGEN Health Care Biotechnology: Biological Products (No Diagnostic Substances)
$40.57
▲ +0.1% Today
as of Jul 22, 16:53 ET
Last 30 days +9.47% Jun 12 → Jul 22
$35.82 $37.48 $39.14 $40.79 $42.45 Jun 12 Jun 22 Jun 29 Jul 08 Jul 15 Jul 22
Open
$37.67
High
$37.80
Low
$36.54
Volume
$1M
Avg Vol
$2M
Mkt Cap
$8.3B
P/E (TTM)
—
Beta
—
52w High
$57.82
52w Low
$32.53
Div Yield
—
Shares Out
—

Recent Press Releases & News last 60 days · 16 items

Jul 15 · 20:05 PR Business Wire
QIAGEN Highlights Molecular Testing Solutions Supporting Response to Growing U.S. Cyclospora Outbreak
Jul 15 · 12:48 PR Business Wire
QIAGEN N.V. to Release Results for Q2 2026 and Hold Webcast
Jul 14 · 21:31 MT Newswires
Qiagen Launches QIAstat-Dx Bloodstream Infection Testing in Europe
▸ Show all 16 press releases & news Free account →

Overview

52-week range
$33
$58
32% of range
Avg surprise (last 3)
+3.3%
Avg reaction (last 2)
+1.2%
100% positive
Latest IV / EM
40%
EM ±9.2% · $40 · Aug 21

Earnings trends

EPS — actual vs estimate Actual Estimate
$0.00$0.28$0.55$0.83$1.10 Actual $0.55Est $0.50Actual $0.60Est $0.60Actual $0.54Est $0.54 Mar/2025Jun/2025Mar/2026

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Wed May 6, 2026Mar/2026 $0.54 $0.54 0.0% -1.8% +1.3% earnings
Tue Aug 5, 2025Jun/2025 $0.60 $0.60 0.0% — — earnings
Wed May 7, 2025Mar/2025 $0.55 $0.50 +10.0% — +1.1% earnings

Upcoming

DateFiscalTimeEPS EstLY EPSYoY %Δ
Wed Aug 5, 2026Jun/2026AMC $0.60$0.63 -4.8%

Implied volatility — last 90 days

38%86%134%182%230% Jun 07 — IV 51% · EM ±7.1%Jun 08 — IV 48% · EM ±6.3%Jun 09 — IV 64% · EM ±8.0%Jun 10 — IV 59% · EM ±7.0%Jun 11 — IV 71% · EM ±7.8%Jun 12 — IV 65% · EM ±6.7%Jun 15 — IV 157% · EM ±11.3%Jun 16 — IV 114% · EM ±6.7%Jun 17 — IV 223% · EM ±9.3%Jun 19 — IV 55% · EM ±12.2%Jun 22 — IV 49% · EM ±10.3%Jun 23 — IV 41% · EM ±8.5%Jun 24 — IV 48% · EM ±9.5%Jun 25 — IV 48% · EM ±9.4%Jun 26 — IV 43% · EM ±8.2%Jun 29 — IV 47% · EM ±8.4%Jun 30 — IV 42% · EM ±7.2%Jul 01 — IV 42% · EM ±7.0%Jul 02 — IV 39% · EM ±6.2%Jul 03 — IV 40% · EM ±6.2%Jul 06 — IV 49% · EM ±6.8%Jul 07 — IV 53% · EM ±7.0%Jul 08 — IV 80% · EM ±10.0%Jul 09 — IV 82% · EM ±9.7%Jul 10 — IV 56% · EM ±6.2%Jul 13 — IV 108% · EM ±9.0%Jul 14 — IV 108% · EM ±7.8%Jul 15 — IV 166% · EM ±9.8%Jul 16 — IV 231% · EM ±9.6%Jul 20 — IV 52% · EM ±12.3%Jul 21 — IV 43% · EM ±10.0%Jul 22 — IV 40% · EM ±9.2%

Sector peers

LLY
Eli Lilly and Company
$1.1T $1,162.23-0.1%
JNJ
Johnson & Johnson
$601.7B $255.02-0.2%
ABBV
AbbVie Inc.
$447.7B $256.20+1.1%
MRK
Merck & Company, Inc.
$307.2B $127.47-0.0%
PM
Philip Morris International Inc
$300.4B $195.00+0.3%
NVS
Novartis AG
$293.4B $152.73-0.2%
View on Nasdaq ↗
🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.
Sign up free → Sign in